Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05103254 · ClinicalTrials.gov registry record
Bempedoic Acid Pregnancy Surveillance Program
A clinical trial of Pregnancy and Hyperlipidemias, sponsored by Esperion Therapeutics.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05103254 is a study of Pregnancy and Hyperlipidemias that is actively recruiting participants, run by Esperion Therapeutics. The registered enrollment target is 20 participants, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05103254, a study of Pregnancy and Hyperlipidemias, is actively recruiting participants, sponsored by Esperion Therapeutics.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Bempedoic acid pregnancy surveillance program
Conditions Studied
Interventions
- DRUG Bempedoic Acid
- DRUG Bempedoic Acid / Ezetimibe
Study Locations (1)
North Carolina
- Evidera, PPD business unit - Morrisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2032-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05103254
The ClinicalTrials.gov registry entry for NCT05103254 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 873-participant average among 191 other Pregnancy trials with a reported enrollment target (98% lower). The listed sponsor is Esperion Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Bempedoic Acid is the first listed.
NCT05103254 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05103254 about?
NCT05103254 is a clinical study titled "Bempedoic Acid Pregnancy Surveillance Program". Bempedoic acid pregnancy surveillance program
What is the current status of trial NCT05103254?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2021-09-01. Estimated completion is 2032-05.
What conditions does trial NCT05103254 study?
This clinical trial studies the following conditions: Pregnancy, Hyperlipidemias.
What interventions are being tested in trial NCT05103254?
The interventions under investigation include: Bempedoic Acid (DRUG), Bempedoic Acid / Ezetimibe (DRUG).
Who is sponsoring clinical trial NCT05103254?
This trial is sponsored by Esperion Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05103254 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.